Sunday, 20 September 2026European Markets

NYRSTAR Stock Jumps By 28% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of NYRSTAR (BEL 20: NYR.BR) rose by a staggering 28.51% in 21 sessions from €0.12 to €0.16 at 11:22 EST on Tuesday, following the last session's downward trend. BEL 20 is jumping 0.07% to €3,687.64, following the last session's upward trend.

NYRSTAR's last close was €0.16, 35.74% under its 52-week high of €0.25.

About NYRSTAR

Nyrstar NV does not have significant operations. Previously, it was engaged in the mining, smelting, and producing of zinc, lead, and other base and precious metals primarily in Europe, Australia, Canada, and the United States. Nyrstar NV was founded in 2007 and is based in Balen, Belgium.

Earnings Per Share

As for profitability, NYRSTAR has a trailing twelve months EPS of €-0.01.

Yearly Top and Bottom Value

NYRSTAR's stock is valued at €0.16 at 11:22 EST, way under its 52-week high of €0.25 and way higher than its 52-week low of €0.11.

Volatility

NYRSTAR's last week, last month's, and last quarter's current intraday variation average was 1.67%, 1.57%, and 2.87%.

NYRSTAR's highest amplitude of average volatility was 5.00% (last week), 2.60% (last month), and 2.87% (last quarter).

More news about NYRSTAR (NYR.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com